Their research lays the groundwork for developing more effective treatments for triple negative breast cancers and mesotheliomas—both aggressive forms of cancer that are difficult to treat.
Lung cancer remains a major global health challenge, characterized by aggressive malignancy and poor prognostic outcomes. This review article focuses on the pivotal role of claudins, a family of tight ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Their research lays the groundwork for developing more effective treatments for triple negative breast cancers and mesotheliomas — both aggressive forms of cancer that are difficult to treat. The new ...
(c) ssGSEA of 87 mesotheliomas from TCGA using SFT gene signature of upregulated genes from Fig 1 (n = 2,429). Shows significant upregulation of the SFT gene signature in the TCGA SH A7BH sample. (d) ...